Francesca Barone - Feb 3, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Scientific Officer
Signature
/s/ John Canepa, as Attorney-In-Fact for Francesca Barone
Stock symbol
CADL
Transactions as of
Feb 3, 2022
Transactions value $
$0
Form type
4
Date filed
2/7/2022, 04:40 PM
Next filing
Mar 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +40K $0.00 40K Feb 3, 2022 Common Stock 40K $4.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments over four years following the Grant Date, subject to the Reporting Person's continued service on each such vesting date.